Editact Company
Editact specializes in the development of novel gene treatments for Alzheimer's disease. It focuses on unmet clinical requirements in familial Alzheimer's disease (FAD) and is developing "one-to-many" gene editing therapeutics.
Industry:
DeepTech
Headquarters:
Hong Kong
Founded Date:
2023